Skip to Main Content

2,481

Views

1

CrossRef citations to date

0

Altmetric

Rheumatoid Arthritis

Effectiveness, safety, and methotrexate dose-tapering pattern over two years of treatment with adalimumab and ≥12 mg/week methotrexate for early rheumatoid arthritis: Results of the HAWK postmarketing surveillance study in Japan

Yoshiya TanakaThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan; Correspondence[email protected]
View further author information

,

Tsuneyo MimoriDepartment of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; View further author information

,

Hisashi YamanakaInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan; View further author information

,

Naomi SunagaAbbVie GK, Tokyo, Japan; View further author information

,

Kazuo MoritaAbbVie GK, Tokyo, Japan; View further author information

,

Junko KimuraAbbVie GK, Tokyo, Japan; View further author information

&

Tsutomu TakeuchiDivision of Rheumatology, Department of Internal Medicine, Keio University, Tokyo, JapanView further author information